PLIANT THERAPEUTICS INC
PLRXNASDAQ🏆 #3937 by market capEarnings Nov 5US Equity
$1.06▲ $0.03 (+2.91%)
Live1h▲ 0.0%
24h▲ 2.9%
7d▲ 0.5%
14d▲ 0.0%
30d▼ 6.2%
1y▼ 36.9%
🏦Market Cap
$66M
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
52
Weak
📊
Analyst Ratings
Price
$1.06
Total
16
Raised
0
Lowered
3
Avg PT
$3.00
H / L
$3 / $3
| Institution | Action | Rating | Date |
|---|---|---|---|
Canaccord Genuity | Reiterated | Hold | 2026-03-13 |
Piper Sandler | Reiterated | Overweight | 2026-03-12 |
RBC Capital | Reiterated | Sector Perform | 2025-11-07 |
JP Morgan | Downgraded | Neutral → Underweight | 2025-10-10 |
HC Wainwright & Co. | Reiterated | Neutral | 2025-03-18 |
Wells Fargo | Reiterated | Equal Weight | 2025-03-04 |
Citigroup | Reiterated | Neutral | 2025-03-04 |
Needham | Downgraded | Buy → Hold | 2025-03-04 |
Leerink Partners | Downgraded | Outperform → Market Perform | 2025-03-03 |
Oppenheimer | Reiterated | Outperform | 2024-08-08 |
Cantor Fitzgerald | Reiterated | Overweight | 2023-08-22 |
Baird | Reiterated | Outperform | 2023-04-13 |
SVB Leerink | Reiterated | Outperform | 2023-01-24 |
Stifel | Reiterated | Buy | 2022-12-14 |
BTIG | Reiterated | Buy | 2021-04-20 |
Cowen & Co. | Reiterated | Outperform | 2020-06-29 |
One row per institution, most recent rating